An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Assay Guidance Manual [Internet].
Markossian S, Grossman A, Arkin M, et al., editors.
Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004-.
Table of contents
Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies.
Strovel J, Sittampalam S, Coussens NP, et al. 2012 May 1 [Updated 2016 Jul 1].
Basic Guidelines for Reporting Non-Clinical Data.
Dahlin JL, Sittampalam GS, Coussens NP, et al. 2019 Oct 1.
Authentication of Human and Mouse Cell Lines by Short Tandem Repeat (STR) DNA Genotype Analysis.
Almeida JL, Korch CT. 2023 Jan 17.
Receptor Binding Assays for HTS and Drug Discovery.
Auld DS, Farmen MW, Kahl SD, et al. 2012 May 1 [Updated 2018 Jul 1].
Compound-Mediated Assay Interferences in Homogeneous Proximity Assays.
Coussens NP, Auld D, Roby P, et al. 2020 Feb 1.
Immunoassay Methods.
Cox KL, Devanarayan V, Kriauciunas A, et al. 2012 May 1 [Updated 2019 Jul 8].
Histone Acetyltransferase Assays in Drug and Chemical Probe Discovery.
Gadhia S, Shrimp JH, Meier JL, et al. 2017 Jul 26 [Updated 2018 Jul 1].
Microplate Selection and Recommended Practices in High-throughput Screening and Quantitative Biology.
Auld DS PhD, Coassin PA BS, Coussens NP PhD, et al. 2020 Jun 1.
Analyzing Kinetic Binding Data.
Hoare SRJ. 2021 Apr 1.
Pluripotent Stem Cell Culture Scale-Out.
Johnson DL, Scott R, Newman R. 2021 Jun 1.
Nuclear Factor Kappa B (NF-κB) Translocation Assay Development and Validation for High Content Screening.
Trask OJ Jr. 2012 Oct 1.
Assay Interference by Aggregation.
Auld DS, Inglese J, Dahlin JL. 2017 Jul 26.
Pharmacological Characterization of GPCR Agonists, Antagonists, Allosteric Modulators and Biased Ligands from HTS Hits to Lead Optimization.
Sum CS, Murphy BJ, Li Z, et al. 2019 Nov 1.
Assay Interference by Chemical Reactivity.
Dahlin JL, Baell J, Walters MA. 2015 Sep 18.
Genome Editing Using Engineered Nucleases and Their Use in Genomic Screening.
Costa JR, Bejcek BE, McGee JE, et al. 2017 Nov 20.
Assay Development Guidelines for Image-Based High Content Screening, High Content Analysis and High Content Imaging.
Buchser W, Collins M, Garyantes T, et al. 2012 Oct 1 [Updated 2014 Sep 22].
FLIPR™ Assays for GPCR and Ion Channel Targets.
Arkin MR, Connor PR, Emkey R, et al. 2012 May 1 [Updated 2012 Oct 1].
Inhibition of Protein-Protein Interactions: Cell-Based Assays.
Wade M, Méndez J, Coussens NP, et al. 2017 Nov 20.
Basics of Assay Equipment and Instrumentation for High Throughput Screening.
Jones E, Michael S, Sittampalam GS. 2012 May 1 [Updated 2016 Apr 2].
Automated Electrophysiology Assays.
Priest BT, Cerne R, Krambis MJ, et al. 2017 Mar 9.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on